EUVIMEDObjevte EUVIMED
Open access

The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey

Shruti Gupta iD, Ishan Gupta iD, Nalini Gupta iD, Bharat Rekhi iD

Diagnostic Cytopathology · 2026-09 · 54 (9) · 644-652

DOI: 10.1002/dc.70154 ↗

At a glance

Journal article in Diagnostic Cytopathology, published online on 2026-06-01. Written by Shruti Gupta and 3 co-authors. Institution: Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Raebareli, India. Major MEDLINE topics: Cytodiagnosis. 25 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Cytopathology is a widely practiced, low‐cost diagnostic modality in India. However, nationwide data on infrastructure, contemporary practices, and use of ancillary techniques remain limited. We conducted a nationwide survey to describe current practice patterns and identify existing gaps. A cross‐sectional online questionnaire (Google Form) was shared amongst practicing pathologists in India from June 12, 2025 to July 15, 2025. The data collected included laboratory type, specimen workload, staining, cell‐block preparation, ancillary testing, adoption of standardized reporting systems, turnaround time (TAT), and use of digital pathology. Descriptive statistics were generated. Of 235 respondents, 84.7% (199/235) reported having a dedicated cytopathology laboratory; 130 (55.3%) were from teaching hospitals. FNAC remains widely practiced throughout the country: 72.8% of FNACs are performed by pathologists and 37% of centers receive > 2000 FNAC cases annually. Cell blocks were prepared in 72.3% (170/235) of centers; ancillary techniques were available in 37.9% (89/235). Standardized reporting systems were used by 80.9% (190/235) respondents, and 50.2% routinely performed ROSE. Only 10.2% had access to whole‐slide imaging and 2.6% reported use of AI tools. A TAT of ≤ 24 h was followed in 46.8% (110/235) centers. Significant differences across center types were observed for reporting patterns, accreditation, ancillary testing, and quality assurance practices ( p < 0.05). Cytopathology services in India are widespread but heterogeneous: infrastructure, ancillary testing, and digital adoption vary significantly with center type. Nation‐wide efforts to standardize reporting, strengthen training in specimen triage, and expand accreditation and EQAS participation are essential to improve uniformity and quality of services.

Subjects

MeSH terms (MEDLINE)

CytodiagnosisIndiaHumansSurveys and QuestionnairesCross-Sectional StudiesBiopsy, Fine-Needle

Author keywords

FNACIndiacell blockcytopathologyliquid‐based cytologysurvey

Authors and institutions

  • Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Raebareli, India.
  • Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Cytology and Gynecologic Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Pathology, Tata Memorial Hospital, Mumbai, India.

ORCID profiles: Shruti Gupta, Ishan Gupta, Nalini Gupta, Bharat Rekhi

Cite

APA

Gupta, S., Gupta, I., Gupta, N., & Rekhi, B. (2026). The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey. Diagnostic Cytopathology, 54(9), 644-652. https://doi.org/10.1002/dc.70154

Vancouver

Gupta S, Gupta I, Gupta N, Rekhi B. The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey. Diagnostic Cytopathology. 2026;54(9):644-652. doi:10.1002/dc.70154

BibTeX
@article{Gupta2026,
  author = {Gupta, Shruti and Gupta, Ishan and Gupta, Nalini and Rekhi, Bharat},
  title = {The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  volume = {54},
  number = {9},
  pages = {644--652},
  doi = {10.1002/dc.70154}
}
Start for free →